CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 22 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,203 | +18.8% | 39,790 | -7.6% | 0.00% | – |
| Q2 2023 | $63,276 | -24.6% | 43,045 | 0.0% | 0.00% | – |
| Q1 2023 | $83,938 | -56.7% | 43,045 | -50.0% | 0.00% | – |
| Q4 2022 | $193,702 | +86.3% | 86,090 | +100.0% | 0.00% | – |
| Q3 2022 | $104,000 | +16.9% | 43,045 | 0.0% | 0.00% | – |
| Q2 2022 | $89,000 | -25.2% | 43,045 | +2.4% | 0.00% | – |
| Q1 2022 | $119,000 | -61.2% | 42,045 | -36.1% | 0.00% | – |
| Q4 2021 | $307,000 | +279.0% | 65,790 | +368.5% | 0.00% | – |
| Q3 2018 | $81,000 | -1.2% | 14,044 | +4.1% | 0.00% | – |
| Q2 2018 | $82,000 | +7.9% | 13,490 | +19.8% | 0.00% | – |
| Q1 2018 | $76,000 | +1.3% | 11,258 | +12.1% | 0.00% | – |
| Q4 2017 | $75,000 | +47.1% | 10,046 | -11.9% | 0.00% | – |
| Q2 2014 | $51,000 | -15.0% | 11,400 | -13.6% | 0.00% | – |
| Q1 2014 | $60,000 | -91.5% | 13,200 | -92.0% | 0.00% | – |
| Q4 2013 | $702,000 | +688.8% | 164,077 | +741.4% | 0.00% | – |
| Q3 2013 | $89,000 | -19.8% | 19,500 | -11.0% | 0.00% | – |
| Q2 2013 | $111,000 | – | 21,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |